- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Do forever chemicals cause thyroid cancer? Study reveals alarming link between the two - Video
Overview
A recent study published in eBioMedicine has uncovered concerning connections between exposure to per- and polyfluoroalkyl substances (PFAS) and the rising trend of thyroid cancer. While suspicions have lingered regarding PFAS exposure as a contributor to thyroid cancer, limited research has delved into this association within human populations. This study sought to bridge that gap, investigating the link between plasma PFAS levels and thyroid cancer diagnoses.
The study conducted a nested case-control investigation, focusing on patients diagnosed with thyroid cancer with plasma samples collected at or before the time of diagnosis. It involved 88 patients with thyroid cancer, using diagnosis codes, and pair-matched them with 88 healthy non-cancer controls. The matching criteria included sex, age (within 5 years), race/ethnicity, body mass index, smoking status, and the year of sample collection. Among the thyroid cancer patients, 74 had papillary thyroid cancer.
Eight plasma PFAS were measured using an untargeted analysis with liquid chromatography-high-resolution mass spectrometry and suspect screening. The study revealed a substantial 56% increase in the rate of thyroid cancer diagnosis per doubling of linear perfluorooctanesulfonic acid (n-PFOS) intensity. The adjusted odds ratio indicated a significant risk. When narrowing the focus to patients with papillary thyroid cancer, the findings were similar.
Further analysis into the timing of exposure unveiled that the positive association persisted for patients diagnosed with thyroid cancer more than a year after plasma sample collection.
Reference: Per- and polyfluoroalkyl substances (PFAS) exposure and thyroid cancer risk, Maaike van Gerwen et al, Published:October 24, 2023 DOI:https://doi.org/10.1016/j.ebiom.2023.104831
Speakers
Isra Zaman
B.Sc Life Sciences, M.Sc Biotechnology, B.Ed